Health policy, health technology assessment, and screening in Europe
article
Objective: To present a summary of the papers in this volume, illustrating the links between health technology assessment (HTA), health policies and specifically policies toward prevention and screening, and implementation of screening tests in the case of three screening methods: mammography screening for breast cancer, screening for prostate cancer, and routine use of ultrasound in pregnancy. Method: To commission papers from eight European countries based on a set of questions to be answered, as well as a paper synthesizing the scientific literature on the three screening procedures. Results: Indicate that few of the countries examined have developed effective links between HTA, health policy, and implementation related to screening procedures. Only Sweden and the Netherlands appear to have developed such links. In the other countries, HTA has a limited role in determining health policy. It also seems to be uncommon for countries to have a specific prevention strategy. Conclusion: The major conclusion is that countries of Europe need to develop HTA as part of prevention policies. Chemicals/CAS: Prostate-Specific Antigen, EC 3.4.21.77
Topics
Health technology assessmentPreventive servicesPSA testingUltrasoundBiomedical technology assessmentBreast cancerHealth care policyPreventive health serviceProstate cancerScientific literatureScreeningScreening testUltrasoundAdultEuropeFemaleHealth PolicyHumansMaleMammographyMass ScreeningMiddle AgedPregnancyProstate-Specific AntigenTechnology Assessment, BiomedicalUltrasonography, Prenatal
TNO Identifier
236181
ISSN
02664623
Source
International Journal of Technology Assessment in Health Care, 17(3), pp. 409-417.
Pages
409-417
Files
To receive the publication files, please send an e-mail request to TNO Repository.